CLEC4A and autoimmune disease: Furthermore, DCIR polymorphisms are linked to patients’ susceptibility to autoimmune diseases such as rheumatoid arthritis (RA) (8), systemic lupus erythematosus (SLE) (9), and primary Sjögren’s syndrome (9).